FIELD: chemistry.
SUBSTANCE: invention relates to naphthyridine derivatives of general formula I in which R1-R6 substituents have the following values: R1 represents NR7R8, R2 represents hydrogen, and R3 represents hydrogen, where R7 represents hydrogen, and R8 can represent -C(Y)NR9R10, where Y represents O, S, and R9 hydrogen and R10 can represent (i) non-substituted saturated C1-6-alkyl, possibly substituted with non-substituted C6-aryl, (ii) non-substituted C6-aryl, R4 represents hydrogen, R5 can represent (i) C6-aryl, substituted with saturated C1-6-alkoxy or hydroxyl, (ii) C5-heteroaryl, containing 2 nitrogen atoms, substituted with saturated C1-6-alkyl, (iii) NR15R16, where R15 represents hydrogen, and R16 represents C6-aryl, substituted with saturated C1-6-alkoxy, and R6 represents hydrogen; and their physiologically acceptable salts, which are kinase modulators.
EFFECT: obtaining novel compounds.
12 cl, 1 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS SUITABLE AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | 2018 |
|
RU2804468C2 |
PYRIDONE AND AZA-PYRIDONE COMPOUNDS AND METHODS OF USE | 2011 |
|
RU2617405C2 |
QUINOLINE-2 DERIVATIVES AS C-KIT KINASE INHIBITORS | 2016 |
|
RU2754858C2 |
MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR | 2011 |
|
RU2576036C2 |
PDE9 INHIBITOR AND ITS USE | 2018 |
|
RU2793732C2 |
SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES | 2013 |
|
RU2644947C2 |
NOVEL PYRAZOLE PYRIMIDINE DERIVATIVES | 2017 |
|
RU2769448C2 |
TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
Authors
Dates
2016-01-20—Published
2010-11-24—Filed